Acrux (ASX: ACR) is a pharmaceutical company dedicated to developing and commercialising specialty and generic topical pharmaceuticals. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and commercialised through licensees a number of pharmaceutical products in the US and Europe using the Patchless PatchTM, a fast-drying and invisible topical application technology. Marketed products include Axiron®, Evamist® and Lenzetto®. More recently, in addition to specialty products, Acrux has identified and initiated development of a range of generic products. Acrux is leveraging its on-site laboratories, GMP manufacturing suite, clinical and commercial experience to bring more products to market. Acrux encourages collaboration and is well positioned to discuss partnering and product development.
Location: Australia, Victoria, Melbourne
Employees: 11-50
Total raised: $7.8M
Founded date: 1998
Investors 2
| Date | Name | Website |
| - | Bioscience... | bioscience... |
| - | Omega Fund... | omegafunds... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.12.2020 | - | $7.8M | - |
Mentions in press and media 5
| Date | Title | Description |
| 17.12.2021 | Acrux : Whistleblower Policy | For personal use only ACRUX LIMITED WHISTLEBLOWER POLICY For personal use only WHISTLEBLOWER POLICY 1. OVERVIEW OF THE POLICY The Directors and management of Acrux Limited and its related bodies corporate (the 'Company') are committed to ma... |
| 02.02.2021 | Acrux : Share Purchase Plan Closes OversubscribedOpens in a new Window | ASX/Media Release 2 February 2021 Share Purchase Plan Closes Oversubscribed Melbourne, Australia; 2 February 2021 Acrux Limited (ASX:ACR, "Acrux" or the "Company") is pleased to confirm that its Share Purchase Plan (&quo... |
| 02.02.2021 | ACRUX LIMITED Acrux : Share Purchase Plan Closes OversubscribedOpens in a new Window | ASX/Media Release 2 February 2021 Share Purchase Plan Closes Oversubscribed Melbourne, Australia; 2 February 2021 Acrux Limited (ASX:ACR, "Acrux" or the "Company") is pleased to confirm that its Share Purchase Plan (&quo... |
| 21.12.2020 | ACRUX LIMITED Acrux : Raises $7.8m Via Placement and Announces SPPOpens in a new Window | ASX/Media Release Monday, 21 December 2020 Acrux raises $7.8 million via two-tranche Placement and announces Share Purchase Plan Acrux conducts successful $7.8 million two-tranche Placement to institutional and sophisticated investors with ... |
| 21.12.2020 | Acrux : Raises $7.8m Via Placement and Announces SPPOpens in a new Window | ASX/Media Release Monday, 21 December 2020 Acrux raises $7.8 million via two-tranche Placement and announces Share Purchase Plan Acrux conducts successful $7.8 million two-tranche Placement to institutional and sophisticated investors with ... |